BioVie Inc. (BIVI) Stock Plummets Following Pricing of its Underwritten Public Offering
BioVie Inc. (BIVI) stock prices plummeted by 35.25% some time after market trading commenced on August 9th, 2021, bringing the price per share down to USD$8.32 early on in the trading day. Underwritten Public Offering August 8th 2021 saw the clinical-stage company announce the pricing of its underwritten public offering of 2.5 million shares of […]
BioVie Inc. (BIVI) Stock Plummets Following Pricing of its Underwritten Public Offering Read More »